Stem Cell Transfusion

PROCEDURE2 trials

Sponsors

Case Comprehensive Cancer Center, Dana-Farber Cancer Institute

Conditions

HemoglobinopathiesLeukemiaLymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesSickle Cell DiseaseThalassemia

Phase 2

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

CompletedNCT00054327

Case Comprehensive Cancer CenterLeukemia, Lymphoma, Myelodysplastic/Myeloproliferative Diseases +1

Start: 2000-11-30End: 2011-09-30Updated: 2013-07-24

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

CompletedNCT00153985

Dana-Farber Cancer InstituteHemoglobinopathies, Sickle Cell Disease, Thalassemia

Start: 2004-03-31End: 2009-07-31Updated: 2013-07-30